Other languages NovAccess Global Inc.

Equities

XSNX

US67001N1072

Delayed OTC Markets Other stock markets 01:45:35 2024-07-11 pm EDT			5-day change	1st Jan Change
0.0125 ^USD	+56.25%		+25.00%	-37.81%

May. 31	NovAccess Global Inc. announced that it has received $0.009 million in funding	CI
May. 21	NovAccess Global Inc. Files Patent with Cedars-Sinai to Advance Its Brain Cancer Fighting Vaccine Platform	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

NovAccess Global Inc. Files Patent with Cedars-Sinai to Advance Its Brain Cancer Fighting Vaccine Platform	May. 21
NovAccess Global Inc. acquired 18.60% stake in Fendix Media Ltd from David Sumner for $0.12 million.	May. 16
NovAccess Global Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	May. 15
NovAccess Global Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	Feb. 27
NovAccess Global Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	Feb. 09
NovAccess Global Inc. Appoints Roscoe M. Moore, Jr. to Scientific Advisory Board	Nov. 10
NovAccess Global Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	23-08-11
NovAccess Global Inc. Partners with BCN Biosciences to Expand Immunotherapy Platform	23-07-27
NovAccess Global Partners with CKN Ventures to Expand its New AI-driven Precision Medicine Division	23-06-16
NovAccess Global Inc. Launches Precision Medicine Division Using AI, Big Data and Predictive Technologies to Accelerate Personalised Healthcare Therapies	23-06-01
NovAccess Global Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	23-05-15
NovAccess Global Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022	23-02-14
NovAccess Global Inc. Reports Earnings Results for the Full Year Ended September 30, 2022	23-01-10
NovAccess Global Inc. Auditor Raises 'Going Concern' Doubt	23-01-09
Novaccess Global Inc. Appoints Peter Weinstein to Scientific Advisory Board	22-11-10
NovAccess Global Inc. Receives FDA Approval of Orphan Drug Application for TLR-AD1	22-10-28
NovAccess Global Receives FDA Approval of Orphan Drug Application for TLR-AD1	22-10-26
NovAccess Global Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022	22-08-15
NovAccess Global Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2022	22-05-16
NovAccess Global Inc. Appoints Jason M. Anderson to the Board	22-03-24

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages NovAccess Global Inc.

Equities

XSNX

US67001N1072

Other languages

Filters